Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Chronic Renal Failure

  Free Subscription


Articles published in Am J Nephrol

Retrieve available abstracts of 99 articles:
HTML format
Text format



Single Articles


    April 2019
  1. KAPOIAN T, Khalil S, O'Mara NB, Brink DM, et al
    Modeled Daily Ingested, Absorbed and Bound Phosphorus: New Measures of Mineral Balance in Hemodialysis Patients.
    Am J Nephrol. 2019;49:368-376.
    PubMed     Text format     Abstract available


  2. JOTWANI VK, Lee AK, Estrella MM, Katz R, et al
    Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease.
    Am J Nephrol. 2019;49:346-355.
    PubMed     Text format     Abstract available


    March 2019
  3. MATSCHKAL J, Mayer CC, Sarafidis PA, Lorenz G, et al
    Comparison of 24-hour and Office Pulse Wave Velocity for Prediction of Mortality in Hemodialysis Patients.
    Am J Nephrol. 2019;49:317-327.
    PubMed     Text format     Abstract available


  4. RIVERA M, Tamariz L, Suarez M, Contreras G, et al
    Modifying Effect of Statins on Fatal Outcomes in Chronic Kidney Disease Patients in the Systolic Blood Pressure Intervention Trial: A Post Hoc Analysis.
    Am J Nephrol. 2019;49:297-306.
    PubMed     Text format     Abstract available


  5. STRUGNELL SA, Sprague SM, Ashfaq A, Petkovich M, et al
    Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease.
    Am J Nephrol. 2019;49:284-293.
    PubMed     Text format     Abstract available


  6. AKIZAWA T, Macdougall IC, Berns JS, Bernhardt T, et al
    Long-Term Efficacy and Safety of Molidustat for Anemia in Chronic Kidney Disease: DIALOGUE Extension Studies.
    Am J Nephrol. 2019;49:271-280.
    PubMed     Text format     Abstract available


    February 2019
  7. JOVANOVICH A, You Z, Isakova T, Nowak K, et al
    Fibroblast Growth Factor 23 Trajectories in Chronic Hemodialysis Patients: Lessons from the HEMO Study.
    Am J Nephrol. 2019;49:263-270.
    PubMed     Text format     Abstract available


  8. SHAH S, Leonard AC, Meganathan K, Christianson AL, et al
    Temporal Trends in Incident Mortality in Dialysis Patients: Focus on Sex and Racial Disparities.
    Am J Nephrol. 2019;49:241-253.
    PubMed     Text format     Abstract available


  9. EMRICH IE, Brandenburg V, Sellier AB, Schauerte J, et al
    Strength of Fibroblast Growth Factor 23 as a Cardiovascular Risk Predictor in Chronic Kidney Disease Weaken by ProBNP Adjustment.
    Am J Nephrol. 2019;49:203-211.
    PubMed     Text format     Abstract available


  10. WANDELL P, Carlsson AC, Li X, Gasevic D, et al
    End-Stage Kidney Diseases in Immigrant Groups: A Nationwide Cohort Study in Sweden.
    Am J Nephrol. 2019;49:186-192.
    PubMed     Text format     Abstract available


    January 2019
  11. AKIZAWA T, Nangaku M, Yamaguchi T, Arai M, et al
    A Placebo-Controlled, Randomized Trial of Enarodustat in Patients with Chronic Kidney Disease Followed by Long-Term Trial.
    Am J Nephrol. 2019;49:165-174.
    PubMed     Text format     Abstract available


  12. BYLSMA LC, Reichert H, Gage SM, Roy-Chaudhury P, et al
    Clinical Outcomes of Arteriovenous Access in Incident Hemodialysis Patients with Medicare Coverage, 2012-2014.
    Am J Nephrol. 2019;49:156-164.
    PubMed     Text format     Abstract available


  13. SCHWANTES-AN TH, Liu S, Stedman M, Decker BS, et al
    Fibroblast Growth Factor 23 Genotype and Cardiovascular Disease in Patients Undergoing Hemodialysis.
    Am J Nephrol. 2019;49:125-132.
    PubMed     Text format     Abstract available


  14. PRASAD PV, Li LP, Thacker JM, Li W, et al
    Cortical Perfusion and Tubular Function as Evaluated by Magnetic Resonance Imaging Correlates with Annual Loss in Renal Function in Moderate Chronic Kidney Disease.
    Am J Nephrol. 2019;49:114-124.
    PubMed     Text format     Abstract available


  15. JIANG K, Lerman LO
    Prediction of Chronic Kidney Disease Progression by Magnetic Resonance Imaging: Where Are We?
    Am J Nephrol. 2019;49:111-113.
    PubMed     Text format    


  16. OLANIRAN KO, Eneanya ND, Allegretti AS, Zhao SH, et al
    Cardiovascular Outcomes in African Americans with Sickle Cell Trait and Chronic Kidney Disease.
    Am J Nephrol. 2019;49:93-102.
    PubMed     Text format     Abstract available


  17. KRAHN RE, Tulowitzki R, Gudleski GD, Murray B, et al
    Effect of Bicarbonate-Buffered Dialysate on Ventricular Arrhythmias in Hemodialysis Patients.
    Am J Nephrol. 2019;49:74-80.
    PubMed     Text format     Abstract available


    December 2018
  18. AJMAL F, Probst J, Brooks J, Hardin J, et al
    Association between Freestanding Dialysis Facility Size and Medicare Quality Incentive Program Performance Scores.
    Am J Nephrol. 2018;49:64-73.
    PubMed     Text format     Abstract available


  19. DAUBRESSE M, Alexander GC, Crews DC, Segev DL, et al
    Trends in Opioid Prescribing Among Hemodialysis Patients, 2007-2014.
    Am J Nephrol. 2018;49:20-31.
    PubMed     Text format     Abstract available


  20. YE X, Kooman JP, van der Sande FM, Canaud B, et al
    Increased Mortality Associated with Higher Pre-Dialysis Serum Sodium Variability: Results of the International MONitoring Dialysis Outcome Initiative.
    Am J Nephrol. 2018;49:1-10.
    PubMed     Text format     Abstract available


  21. LEE T, Qian J, Thamer M, Allon M, et al
    Gender Disparities in Vascular Access Surgical Outcomes in Elderly Hemodialysis Patients.
    Am J Nephrol. 2018;49:11-19.
    PubMed     Text format     Abstract available


    November 2018
  22. BURROWS NR, Vassalotti JA, Saydah SH, Stewart R, et al
    Identifying High-Risk Individuals for Chronic Kidney Disease: Results of the CHERISH Community Demonstration Project.
    Am J Nephrol. 2018;48:447-455.
    PubMed     Text format     Abstract available


  23. GUILLOTEAU S, Lobbedez T, Guillouet S, Verger C, et al
    Impact of Assisted Peritoneal Dialysis Modality on Outcomes: A Cohort Study of the French Language Peritoneal Dialysis Registry.
    Am J Nephrol. 2018;48:425-433.
    PubMed     Text format     Abstract available


  24. FITZPATRICK J, Sozio SM, Jaar BG, McAdams-DeMarco MA, et al
    Association of Abdominal Adiposity with Cardiovascular Mortality in Incident Hemodialysis.
    Am J Nephrol. 2018;48:406-414.
    PubMed     Text format     Abstract available


  25. KO GJ, Obi Y, Soohoo M, Chang TI, et al
    No Survival Benefit in Octogenarians and Nonagenarians with Extended Hemodialysis Treatment Time.
    Am J Nephrol. 2018;48:389-398.
    PubMed     Text format     Abstract available


  26. JANSZ TT, van Reekum FE, Ozyilmaz A, de Jong PA, et al
    Coronary Artery Calcification in Hemodialysis and Peritoneal Dialysis.
    Am J Nephrol. 2018;48:369-377.
    PubMed     Text format     Abstract available


    October 2018
  27. LYU B, Banerjee T, Scialla JJ, Shafi T, et al
    Vascular Calcification Markers and Hemodialysis Vascular Access Complications.
    Am J Nephrol. 2018;48:330-338.
    PubMed     Text format     Abstract available


  28. BIKOS A, Angeloudi E, Memmos E, Loutradis C, et al
    A Comparative Study of Short-Term Blood Pressure Variability in Hemodialysis Patients with and without Intradialytic Hypertension.
    Am J Nephrol. 2018;48:295-305.
    PubMed     Text format     Abstract available


  29. KOSMADAKIS G, Albaret J, da Costa Correia E, Somda F, et al
    Gastrointestinal Disorders in Peritoneal Dialysis Patients.
    Am J Nephrol. 2018;48:319-325.
    PubMed     Text format     Abstract available


  30. CHEN YJ, Yeung L, Sun CC, Huang CC, et al
    Age-Related Macular Degeneration in Chronic Kidney Disease: A Meta-Analysis of Observational Studies.
    Am J Nephrol. 2018;48:278-291.
    PubMed     Text format     Abstract available


  31. JADOON A, Mathew AV, Byun J, Gadegbeku CA, et al
    Gut Microbial Product Predicts Cardiovascular Risk in Chronic Kidney Disease Patients.
    Am J Nephrol. 2018;48:269-277.
    PubMed     Text format     Abstract available


  32. MACDOUGALL IC, White C, Anker SD, Bhandari S, et al
    Randomized Trial Comparing Proactive, High-Dose versus Reactive, Low-Dose Intravenous Iron Supplementation in Hemodialysis (PIVOTAL): Study Design and Baseline Data.
    Am J Nephrol. 2018;48:260-268.
    PubMed     Text format     Abstract available


    September 2018
  33. AZMANDIAN J, Abbasi MR, Pourfarziani V, Nasiri AA, et al
    Comparing Therapeutic Efficacy and Safety of Epoetin Beta and Epoetin Alfa in the Treatment of Anemia in End-Stage Renal Disease Hemodialysis Patients.
    Am J Nephrol. 2018;48:251-259.
    PubMed     Text format     Abstract available


  34. THADHANI R, Guilatco R, Hymes J, Maddux FW, et al
    Switching from Epoetin Alfa (Epogen(R)) to Epoetin Alfa-Epbx (RetacritTM) Using a Specified Dosing Algorithm: A Randomized, Non-Inferiority Study in Adults on Hemodialysis.
    Am J Nephrol. 2018;48:214-224.
    PubMed     Text format     Abstract available


  35. HAYASHI T, Yasuda K, Kimura T, Sasaki K, et al
    Prognostic Significance of Asymptomatic Brain Natriuretic Peptide Elevation at Nephrology Referral in Patients with Chronic Kidney Disease.
    Am J Nephrol. 2018;48:205-213.
    PubMed     Text format     Abstract available


  36. GARZA-MAYERS AC, Shah R, Sykes DB, Nigwekar SU, et al
    The Successful Use of Apixaban in Dialysis Patients with Calciphylaxis Who Require Anticoagulation: A Retrospective Analysis.
    Am J Nephrol. 2018;48:168-171.
    PubMed     Text format     Abstract available


  37. WARSAME F, Ying H, Haugen CE, Thomas AG, et al
    Intradialytic Activities and Health-Related Quality of Life Among Hemodialysis Patients.
    Am J Nephrol. 2018;48:181-189.
    PubMed     Text format     Abstract available


  38. ZOCCALI C, Mallamaci F
    A New Treatment for Calciphylaxis in Hemodialysis Patients?
    Am J Nephrol. 2018;48:165-167.
    PubMed     Text format    


  39. AGARWAL R, Rossignol P, Garza D, Mayo MR, et al
    Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease: Rationale and Design of the AMBER Study.
    Am J Nephrol. 2018;48:172-180.
    PubMed     Text format     Abstract available


  40. SHINFUKU A, Shimazaki T, Fujiwara M, Sato F, et al
    Novel Compound Induces Erythropoietin Secretion through Liver Effects in Chronic Kidney Disease Patients and Healthy Volunteers.
    Am J Nephrol. 2018;48:157-164.
    PubMed     Text format     Abstract available


    August 2018
  41. KERNS ES, Kim ED, Meoni LA, Sozio SM, et al
    Obstructive Sleep Apnea Increases Sudden Cardiac Death in Incident Hemodialysis Patients.
    Am J Nephrol. 2018;48:147-156.
    PubMed     Text format     Abstract available


  42. DAUGIRDAS JT
    Changes in Total Protein Concentration Due to Fluid Removal During and Shortly after Hemodialysis.
    Am J Nephrol. 2018;48:118-126.
    PubMed     Text format     Abstract available


  43. DROSOS G, Ampatzidou F, Sarafidis P, Karaiskos T, et al
    Serum Creatinine and Chronic Kidney Disease-Epidemiology Estimated Glomerular Filtration Rate: Independent Predictors of Renal Replacement Therapy following Cardiac Surgery.
    Am J Nephrol. 2018;48:108-117.
    PubMed     Text format     Abstract available


  44. IKENOUE T, Koike K, Fukuma S, Ogata S, et al
    Salt Intake and All-Cause Mortality in Hemodialysis Patients.
    Am J Nephrol. 2018;48:87-95.
    PubMed     Text format     Abstract available


  45. MOVILLI E, Camerini C, Gaggia P, Zubani R, et al
    Use of Renin-Angiotensin System Blockers Increases Serum Potassium in Anuric Hemodialysis Patients.
    Am J Nephrol. 2018;48:79-86.
    PubMed     Text format     Abstract available


    July 2018
  46. ZHOU H, Yang M, Jiang Z, Ding J, et al
    Renal Hypoxia: An Important Prognostic Marker in Patients with Chronic Kidney Disease.
    Am J Nephrol. 2018;48:46-55.
    PubMed     Text format     Abstract available


  47. AIRY M, Schold JD, Jolly SE, Arrigain S, et al
    Cause-Specific Mortality in Patients with Chronic Kidney Disease and Atrial Fibrillation.
    Am J Nephrol. 2018;48:36-45.
    PubMed     Text format     Abstract available


  48. SHAH S, Leonard AC, Meganathan K, Christianson AL, et al
    Gender and Racial Disparities in Initial Hemodialysis Access and Outcomes in Incident End-Stage Renal Disease Patients.
    Am J Nephrol. 2018;48:4-14.
    PubMed     Text format     Abstract available


    June 2018
  49. BLUM D, Chan CT
    Iatrogenesis Imperfecta Medicamentosa: Adverse Drug Events in Dialysis Patients are Associated with Higher Resource Utilization and Mortality.
    Am J Nephrol. 2018;47:438-440.
    PubMed     Text format    


  50. CHAN L, Saha A, Poojary P, Chauhan K, et al
    National Trends in Emergency Room Visits of Dialysis Patients for Adverse Drug Reactions.
    Am J Nephrol. 2018;47:441-449.
    PubMed     Text format     Abstract available


  51. DOSHI S, Wish JB
    Can Emergency Department Visits for Adverse Drug Reactions in Dialysis Patients be Reduced?
    Am J Nephrol. 2018;47:435-437.
    PubMed     Text format    


  52. LEE T, Shah S, Leonard AC, Parikh P, et al
    Acute Kidney Injury before Dialysis Initiation Predicts Adverse Outcomes in Hemodialysis Patients.
    Am J Nephrol. 2018;47:427-434.
    PubMed     Text format     Abstract available


  53. FERREY A, You AS, Kovesdy CP, Nakata T, et al
    Dialysate Potassium and Mortality in a Prospective Hemodialysis Cohort.
    Am J Nephrol. 2018;47:415-423.
    PubMed     Text format     Abstract available


  54. MARUYAMA N, Otsuki T, Yoshida Y, Nagura C, et al
    Ferric Citrate Decreases Fibroblast Growth Factor 23 and Improves Erythropoietin Responsiveness in Hemodialysis Patients.
    Am J Nephrol. 2018;47:406-414.
    PubMed     Text format     Abstract available


  55. GREGG LP, Tio MC, Li X, Adams-Huet B, et al
    Association of Monocyte Chemoattractant Protein-1 with Death and Atherosclerotic Events in Chronic Kidney Disease.
    Am J Nephrol. 2018;47:395-405.
    PubMed     Text format     Abstract available


    May 2018
  56. YANG X, Tong Y, Yan H, Ni Z, et al
    High Intraperitoneal Interleukin-6 Levels Predict Peritonitis in Peritoneal Dialysis Patients: A Prospective Cohort Study.
    Am J Nephrol. 2018;47:317-324.
    PubMed     Text format     Abstract available


  57. KLEINE CE, Soohoo M, Ranasinghe ON, Park C, et al
    Association of Pre-End-Stage Renal Disease Hemoglobin with Early Dialysis Outcomes.
    Am J Nephrol. 2018;47:333-342.
    PubMed     Text format     Abstract available


  58. IWASHITA Y, Ohya M, Yashiro M, Sonou T, et al
    Dietary Changes Involving Bifidobacterium longum and Other Nutrients Delays Chronic Kidney Disease Progression.
    Am J Nephrol. 2018;47:325-332.
    PubMed     Text format     Abstract available


    April 2018
  59. ZOCCALI C, Mallamaci F
    Obestatin, a Ghrelin-Cognate Protein, and Clinical Outcomes in Hemodialysis Patients.
    Am J Nephrol. 2018;47:251-253.
    PubMed     Text format    


  60. BEBERASHVILI I, Katkov A, Sinuani I, Azar A, et al
    Serum Obestatin: A Biomarker of Cardiovascular and All-Cause Mortality in Hemodialysis Patients.
    Am J Nephrol. 2018;47:254-265.
    PubMed     Text format     Abstract available


  61. CHAN CT, Kaysen GA, Beck GJ, Li M, et al
    Changes in Biomarker Profile and Left Ventricular Hypertrophy Regression: Results from the Frequent Hemodialysis Network Trials.
    Am J Nephrol. 2018;47:208-217.
    PubMed     Text format     Abstract available


    March 2018
  62. NORMAND G, Xu X, Panaye M, Jolivot A, et al
    Pregnancy Outcomes in French Hemodialysis Patients.
    Am J Nephrol. 2018;47:219-227.
    PubMed     Text format     Abstract available


  63. TAN J, Mehrotra A, Nadkarni GN, He JC, et al
    Telenephrology: Providing Healthcare to Remotely Located Patients with Chronic Kidney Disease.
    Am J Nephrol. 2018;47:200-207.
    PubMed     Text format     Abstract available


  64. CHEN W, Bushinsky DA
    Addressing Racial Disparity in the Progression of Chronic Kidney Disease: Prescribe More Fruits and Vegetables?
    Am J Nephrol. 2018;47:171-173.
    PubMed     Text format    


  65. CREWS DC, Banerjee T, Wesson DE, Morgenstern H, et al
    Race/Ethnicity, Dietary Acid Load, and Risk of End-Stage Renal Disease among US Adults with Chronic Kidney Disease.
    Am J Nephrol. 2018;47:174-181.
    PubMed     Text format     Abstract available


  66. KALANTAR-ZADEH K, Parameswaran V, Ficociello LH, Anderson L, et al
    Real-World Scenario Improvements in Serum Phosphorus Levels and Pill Burden in Peritoneal Dialysis Patients Treated with Sucroferric Oxyhydroxide.
    Am J Nephrol. 2018;47:153-161.
    PubMed     Text format     Abstract available


    February 2018
  67. PATZER RE, Basu M, Smith KD, Plantinga L, et al
    Awareness of the New Kidney Allocation System among United States Dialysis Providers with Low Waitlisting.
    Am J Nephrol. 2018;47:115-119.
    PubMed     Text format     Abstract available


  68. KIM JK, Song YR, Lee HS, Kim HJ, et al
    Repeated Bioimpedance Measurements Predict Prognosis of Peritoneal Dialysis Patients.
    Am J Nephrol. 2018;47:120-129.
    PubMed     Text format     Abstract available


  69. WISH JB, Aronoff GR, Bacon BR, Brugnara C, et al
    Positive Iron Balance in Chronic Kidney Disease: How Much is Too Much and How to Tell?
    Am J Nephrol. 2018;47:72-83.
    PubMed     Text format     Abstract available


  70. SINGH M, Raghavan D, Williams JS, Martin BC, et al
    Prevalence of Chronic Kidney Disease, Thrombotic Cardiovascular Events, and Use of Oral P2Y12 Inhibitors among Veterans.
    Am J Nephrol. 2018;47:67-71.
    PubMed     Text format     Abstract available


    January 2018
  71. SUMIDA K, Yamamoto S, Akizawa T, Fukuhara S, et al
    Body Mass Index Change and Hospitalization Risk in Elderly Hemodialysis Patients: Results from Japanese Dialysis Outcomes and Practice Patterns Study.
    Am J Nephrol. 2018;47:48-56.
    PubMed     Text format     Abstract available


  72. CHIN MP, Bakris GL, Block GA, Chertow GM, et al
    Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study.
    Am J Nephrol. 2018;47:40-47.
    PubMed     Text format     Abstract available


  73. TRIEBSWETTER S, Gutjahr-Lengsfeld LJ, Schmidt KR, Drechsler C, et al
    Long-Term Survivor Characteristics in Hemodialysis Patients with Type 2 Diabetes.
    Am J Nephrol. 2018;47:30-39.
    PubMed     Text format     Abstract available


    December 2017
  74. DIVANI M, Georgianos PI, Didangelos T, Iliadis F, et al
    Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
    Am J Nephrol. 2017;47:21-29.
    PubMed     Text format     Abstract available


  75. MOLITCH ME
    Glycemic Control Assessment in the Dialysis Patient: Is Glycated Albumin the Answer?
    Am J Nephrol. 2017;47:18-20.
    PubMed     Text format    


  76. JONES D, You Z, Kendrick JB
    Racial/Ethnic Differences in Barriers to Kidney Transplant Evaluation among Hemodialysis Patients.
    Am J Nephrol. 2017;47:1-7.
    PubMed     Text format     Abstract available


  77. MC CAUSLAND FR, Claggett B, Pfeffer MA, Burdmann EA, et al
    Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial.
    Am J Nephrol. 2017;46:488-497.
    PubMed     Text format     Abstract available


    November 2017
  78. KIDO R, Akizawa T, Fukagawa M, Onishi Y, et al
    Interactive Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers or Their Combination on Survival of Hemodialysis Patients.
    Am J Nephrol. 2017;46:439-447.
    PubMed     Text format     Abstract available


  79. SUMIDA K, Diskin CD, Molnar MZ, Potukuchi PK, et al
    Pre-End-Stage Renal Disease Hemoglobin Variability Predicts Post-End-Stage Renal Disease Mortality in Patients Transitioning to Dialysis.
    Am J Nephrol. 2017;46:397-407.
    PubMed     Text format     Abstract available


  80. CATABAY C, Obi Y, Streja E, Soohoo M, et al
    Lymphocyte Cell Ratios and Mortality among Incident Hemodialysis Patients.
    Am J Nephrol. 2017;46:408-416.
    PubMed     Text format     Abstract available


  81. MALHOTRA R, Tao X, Wang Y, Chen Y, et al
    Performance of the Surprise Question Compared to Prediction Models in Hemodialysis Patients: A Prospective Study.
    Am J Nephrol. 2017;46:390-396.
    PubMed     Text format     Abstract available


  82. TOMINAGA N, Kida K, Inomata T, Sato N, et al
    Effects of Tolvaptan Addition to Furosemide in Normo- and Hyponatremia Patients with Heart Failure and Chronic Kidney Disease Stages G3b-5: A Subanalysis of the K-STAR Study.
    Am J Nephrol. 2017;46:417-426.
    PubMed     Text format     Abstract available


    October 2017
  83. WEIR MR, Pergola PE, Agarwal RL, Fink JC, et al
    A Comparison of the Safety and Efficacy of HX575 (Epoetin Alfa Proposed Biosimilar) with Epoetin Alfa in Patients with End-Stage Renal Disease.
    Am J Nephrol. 2017;46:364-370.
    PubMed     Text format     Abstract available


  84. MADUELL F, Varas J, Ramos R, Martin-Malo A, et al
    Hemodiafiltration Reduces All-Cause and Cardiovascular Mortality in Incident Hemodialysis Patients: A Propensity-Matched Cohort Study.
    Am J Nephrol. 2017;46:288-297.
    PubMed     Text format     Abstract available


  85. LAM NN, Garg AX, Knoll GA, Kim SJ, et al
    Venous Thromboembolism and the Risk of Death and Graft Loss in Kidney Transplant Recipients.
    Am J Nephrol. 2017;46:343-354.
    PubMed     Text format     Abstract available


    September 2017
  86. SAULNIER PJ, Dieter BP, Tanamas SK, McPherson SM, et al
    Association of Serum Amyloid A with Kidney Outcomes and All-Cause Mortality in American Indians with Type 2 Diabetes.
    Am J Nephrol. 2017;46:276-284.
    PubMed     Text format     Abstract available


  87. MUREA M, Brown WM, Divers J, Moossavi S, et al
    Vascular Access Placement Order and Outcomes in Hemodialysis Patients: A Longitudinal Study.
    Am J Nephrol. 2017;46:268-275.
    PubMed     Text format     Abstract available


  88. LEONBERG-YOO AK, Rudnick MR
    Tobacco Use: A Chronic Kidney Disease Accelerant.
    Am J Nephrol. 2017;46:257-259.
    PubMed     Text format    


  89. ROEHM B, Simoni J, Pruszynski J, Wesson DE, et al
    Cigarette Smoking Attenuates Kidney Protection by Angiotensin-Converting Enzyme Inhibition in Nondiabetic Chronic Kidney Disease.
    Am J Nephrol. 2017;46:260-267.
    PubMed     Text format     Abstract available


  90. LIN MC, Streja E, Soohoo M, Hanna M, et al
    Warfarin Use and Increased Mortality in End-Stage Renal Disease.
    Am J Nephrol. 2017;46:249-256.
    PubMed     Text format     Abstract available


    August 2017
  91. HARDING K, Mersha TB, Pham PT, Waterman AD, et al
    Health Disparities in Kidney Transplantation for African Americans.
    Am J Nephrol. 2017;46:165-175.
    PubMed     Text format     Abstract available


    May 2017
  92. FERREIRA A, Felipe C, Cristelli M, Viana L, et al
    Donor-Specific Anti-Human Leukocyte Antigens Antibodies, Acute Rejection, Renal Function, and Histology in Kidney Transplant Recipients Receiving Tacrolimus and Everolimus.
    Am J Nephrol. 2017;45:497-508.
    PubMed     Text format     Abstract available


    January 2017
  93. KOVESDY CP, Furth SL, Zoccali C
    Obesity and Kidney Disease: Hidden Consequences of the Epidemic.
    Am J Nephrol. 2017;45:283-291.
    PubMed     Text format     Abstract available


  94. PAYAN SCHOBER F, Jobson MA, Poulton CJ, Singh HK, et al
    Clinical Features and Outcomes of a Racially Diverse Population with Fibrillary Glomerulonephritis.
    Am J Nephrol. 2017;45:248-256.
    PubMed     Text format     Abstract available


  95. COLLISTER D, Sathianathan C, Ryz K, Karpinski M, et al
    ANCA Associated Vasculitis Secondary to Levamisole-Adultered Cocaine with Associated Membranous Nephropathy: A Case Series.
    Am J Nephrol. 2017;45:209-216.
    PubMed     Text format     Abstract available


  96. SARAFIDIS PA
    Online Hemodiafiltration Improves Outcomes in Incident Patients with End-Stage Renal Disease: Another Brick in the Wall?
    Am J Nephrol. 2017;46:285-287.
    PubMed     Text format    


  97. QIU W, Jiang Y, Wu J, Huang H, et al
    Simple Cysts in Donor Kidney Contribute to Reduced Allograft Function.
    Am J Nephrol. 2017;45:82-88.
    PubMed     Text format     Abstract available


  98. HEMPEL JC, Poppelaars F, Gaya da Costa M, Franssen CF, et al
    Distinct in vitro Complement Activation by Various Intravenous Iron Preparations.
    Am J Nephrol. 2017;45:49-59.
    PubMed     Text format     Abstract available


    December 2016
  99. TABER DJ, Fleming JN, Fominaya CE, Gebregziabher M, et al
    The Impact of Health Care Appointment Non-Adherence on Graft Outcomes in Kidney Transplantation.
    Am J Nephrol. 2016;45:91-98.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: